Stockscreener 앱 받기
25.86
2.42%
-0.64
시간 외 거래:
26.20
0.34
+1.31%
전일 마감가:
$26.50
열려 있는:
$25.88
하루 거래량:
626.38K
Relative Volume:
0.47
시가총액:
$2.05B
수익:
-
순이익/손실:
$-64.16M
주가수익비율:
-20.36
EPS:
-1.2702
순현금흐름:
$-69.06M
1주 성능:
-3.90%
1개월 성능:
+6.95%
6개월 성능:
-10.08%
1년 성능:
-25.71%
1일 변동 폭
$25.59
$26.64
1주일 범위
$25.48
$28.00
52주 변동 폭
$14.80
$40.47
Cg Oncology Inc Stock (CGON) Company Profile
명칭
Cg Oncology Inc
전화
(949) 419-6203
주소
400 SPECTRUM CENTER DRIVE, IRVINE
CGON을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CGON
Cg Oncology Inc
|
25.86 | 2.05B | 0 | -64.16M | -69.06M | -1.2702 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.45 | 115.69B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
529.24 | 53.25B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
307.99 | 39.22B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
577.89 | 35.78B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
269.63 | 27.68B | 3.81B | -644.79M | -669.77M | -6.24 |
Cg Oncology Inc Stock (CGON) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-02 | 개시 | JP Morgan | Overweight |
| 2025-04-16 | 개시 | Scotiabank | Sector Perform |
| 2025-01-07 | 개시 | TD Cowen | Buy |
| 2024-10-24 | 개시 | UBS | Buy |
| 2024-09-23 | 개시 | RBC Capital Mkts | Outperform |
| 2024-08-28 | 개시 | ROTH MKM | Buy |
| 2024-06-28 | 개시 | BofA Securities | Buy |
| 2024-02-20 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-02-20 | 개시 | Goldman | Neutral |
| 2024-02-20 | 개시 | Morgan Stanley | Overweight |
| 2024-02-14 | 개시 | H.C. Wainwright | Buy |
모두보기
Cg Oncology Inc 주식(CGON)의 최신 뉴스
Cantor Fitzgerald Predicts CG Oncology FY2026 Earnings - Defense World
California State Teachers Retirement System Buys 20,763 Shares of CG Oncology, Inc. (NASDAQ:CGON) - Defense World
Squarepoint Ops LLC Makes New Investment in CG Oncology, Inc. (NASDAQ:CGON) - Defense World
CG Oncology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference - Bluefield Daily Telegraph
CG Oncology Brings Breakthrough Bladder Cancer Treatment to Goldman Sachs Healthcare Conference - Stock Titan
Ameriprise Financial Inc. Grows Stock Holdings in CG Oncology, Inc. (NASDAQ:CGON) - Defense World
Promising Market Position and Investment Opportunity: CG Oncology’s Creto in NMIBC Treatment - TipRanks
CG Oncology, Inc. (NASDAQ:CGON) Position Reduced by Nuveen Asset Management LLC - Defense World
BNP Paribas Financial Markets Lowers Stake in CG Oncology, Inc. (NASDAQ:CGON) - Defense World
CG Oncology, Inc. (NASDAQ:CGON) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
CG Oncology’s SWOT analysis: bladder cancer treatment stock shows promise amid competition - Investing.com
Bank of America Corp DE Has $6.01 Million Stake in CG Oncology, Inc. (NASDAQ:CGON) - Defense World
Millennium Management LLC Invests $7.14 Million in CG Oncology, Inc. (NASDAQ:CGON) - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Purchases 1,026 Shares of CG Oncology, Inc. (NASDAQ:CGON) - Defense World
CGON Stock Rallies 27% in a Month on Bladder Cancer Study Success - MSN
Deutsche Bank AG Acquires 13,589 Shares of CG Oncology, Inc. (NASDAQ:CGON) - Defense World
CG Oncology (NASDAQ:CGON) Given New $52.00 Price Target at Morgan Stanley - Defense World
CGON Stock Rating Maintained by Morgan Stanley Despite Price Target Cut | CGON Stock News - GuruFocus
Cantor Fitzgerald Lowers Earnings Estimates for CG Oncology - Defense World
CG Oncology, Inc. (NASDAQ:CGON) Position Boosted by Northern Trust Corp - Defense World
Q2 Earnings Forecast for CG Oncology Issued By HC Wainwright - Defense World
CG Oncology to Participate in the 2025 RBC Capital Markets Global Healthcare Conference - The Manila Times
Leading Bladder Cancer Drug Developer CG Oncology Takes Stage at Major RBC Healthcare Conference - Stock Titan
Analysts Are Bullish on These NA Stocks: American Healthcare REIT, Inc. (AHR), CG Oncology, Inc. (CGON) - The Globe and Mail
CG Oncology (NASDAQ:CGON) Shares Gap Down on Disappointing Earnings - Defense World
Decoding CG Oncology Inc (CGON): A Strategic SWOT Insight - GuruFocus
CG Oncology reports Q1 EPS (45c), consensus (37c) - TipRanks
CGON Q1 Revenue Falls Short; Advances in Bladder Cancer Therapy - GuruFocus
CG Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates - ADVFN
CG Oncology, Inc. (CGON) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance
CG Oncology Q1 Loss Widens, Revenue Falls - marketscreener.com
CG Oncology, Inc. SEC 10-Q Report - TradingView
CG Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Here Are Reasons Why Cg Oncology Inc (NASDAQ: CGON) Is A Great Choice Now - Stocksregister
CG Oncology Jumps 25% on Positive Trial Results - Orange County Business Journal
CG Oncology (NASDAQ:CGON) Earns Overweight Rating from Analysts at JPMorgan Chase & Co. - Defense World
CG Oncology, Inc. (NASDAQ:CGON) Given Consensus Recommendation of “Buy” by Analysts - Defense World
CG Oncology, Inc. (NASDAQ:CGON) Shares Purchased by Invesco Ltd. - Defense World
CG Oncology initiated with an Overweight at JPMorgan - TipRanks
CGON Stock: JP Morgan Initiates Coverage with Overweight Rating - GuruFocus
JPMorgan Initiates Coverage on CG Oncology With Overweight Rating, $41 Price Target - marketscreener.com
CGON: JPMorgan Starts Coverage with Overweight Rating and $41 Ta - GuruFocus
CG Oncology (NASDAQ:CGON) Reaches New 1-Year Low After Insider Selling - Defense World
CGON: JPMorgan Starts Coverage with Overweight Rating and $41 Target | CGON Stock News - GuruFocus
Why CG Oncology, Inc. (CGON) Surged on Monday - MSN
CG Oncology, Inc. (CGON) May Report Negative Earnings: Know the Trend Ahead of Q1 Release - Yahoo Finance
Cg Oncology Inc’s (CGON) Stock Is Harder To Predict Than You Think - Stocksregister
SUO-CTC and CG Oncology Announce the 2025 Award Recipients for the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award - The Manila Times
CG Oncology, Inc. (NASDAQ:CGON) Shares Bought by Wells Fargo & Company MN - Defense World
AUA hoorays in bladder cancer for J&J, Urogen, more - BioWorld MedTech
A look into Cg Oncology Inc (CGON)’s deeper side - Sete News
Cg Oncology Inc (CGON) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.91%
1.17%
자본화:
|
볼륨(24시간):